Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
27 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-8 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Metastat, Inc.
Metastat, Inc. is a biotechnology company that focuses on the development of novel therapeutics to target metastatic cancer. The company is dedicated to addressing the critical issue of metastasis, which is the primary cause of deaths in cancer patients. Metastasis occurs when cancer spreads from its original site to other parts of the body. Metastat, Inc. aims to develop innovative drugs and treatments that can effectively inhibit the spread of cancer cells and improve patient outcomes. They utilize advanced research and technology to identify and target specific molecular pathways involved in metastasis. Their ultimate goal is to provide patients with new and effective options to combat metastatic cancer and improve the quality of life for those affected by this devastating disease.
|